Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subodh Verma

Showing results (501-510 of 616) with videos related to

Pageof 62
Sort By:
Journal of the American College of Cardiology|November 17, 2024
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyKershaw V Patel, Zainali Chunawala, Subodh Verma, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
The Canadian Journal of Cardiology|September 10, 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationLaurent Macle, John Cairns, Kori Leblanc, et al.
The Canadian Journal of Cardiology|July 28, 2014
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart diseaseG B John Mancini, Gilbert Gosselin, Benjamin Chow, et al.
Circulation|November 8, 2021
Blood Pressure, Hypertension, and the Risk of Aortic Dissection Incidence and Mortality: Results From the J-SCH Study, the UK Biobank Study, and a Meta-Analysis of Cohort StudiesMakoto Hibino, Yoichiro Otaki, Elsa Kobeissi, et al.
Lancet (London, England)|September 4, 2025
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trialSubodh Verma, Lawrence A Leiter, Hwee Teoh, et al.
Canadian Journal of Kidney Health and Disease|January 13, 2018
Risk of Acute Kidney Injury in Patients Randomized to a Restrictive Versus Liberal Approach to Red Blood Cell Transfusion in Cardiac Surgery: A Substudy Protocol of the Transfusion Requirements in Cardiac Surgery III Noninferiority TrialAmit X Garg, Nadine Shehata, Shay McGuinness, et al.
Lancet (London, England)|September 2, 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail N Kosiborod, John Deanfield, Richard Pratley, et al.
European Journal of Preventive Cardiology|June 16, 2026
Early versus delayed evolocumab treatment and complex coronary artery revascularizationPaul M Haller, Prakriti Gaba, Colleen Thomas, et al.
Journal of the American Heart Association|March 9, 2022
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCIBenjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, et al.
Pageof 62

Showing results (501-510 of 616) with videos related to

Sort By:
Pageof 62
Journal of the American College of Cardiology|November 17, 2024
Intensive Lifestyle Intervention, Cardiac Biomarkers, and Cardiovascular Outcomes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary StudyKershaw V Patel, Zainali Chunawala, Subodh Verma, et al.
Journal of the American College of Cardiology|May 31, 2024
Semaglutide and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF ProgramMark C Petrie, Barry A Borlaug, Javed Butler, et al.
The Canadian Journal of Cardiology|September 10, 2016
2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial FibrillationLaurent Macle, John Cairns, Kori Leblanc, et al.
The Canadian Journal of Cardiology|July 28, 2014
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart diseaseG B John Mancini, Gilbert Gosselin, Benjamin Chow, et al.
Circulation|November 8, 2021
Blood Pressure, Hypertension, and the Risk of Aortic Dissection Incidence and Mortality: Results From the J-SCH Study, the UK Biobank Study, and a Meta-Analysis of Cohort StudiesMakoto Hibino, Yoichiro Otaki, Elsa Kobeissi, et al.
Lancet (London, England)|September 4, 2025
Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery (NEWTON-CABG CardioLink-5): an international, randomised, double-blind, placebo-controlled trialSubodh Verma, Lawrence A Leiter, Hwee Teoh, et al.
Canadian Journal of Kidney Health and Disease|January 13, 2018
Risk of Acute Kidney Injury in Patients Randomized to a Restrictive Versus Liberal Approach to Red Blood Cell Transfusion in Cardiac Surgery: A Substudy Protocol of the Transfusion Requirements in Cardiac Surgery III Noninferiority TrialAmit X Garg, Nadine Shehata, Shay McGuinness, et al.
Lancet (London, England)|September 2, 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail N Kosiborod, John Deanfield, Richard Pratley, et al.
European Journal of Preventive Cardiology|June 16, 2026
Early versus delayed evolocumab treatment and complex coronary artery revascularizationPaul M Haller, Prakriti Gaba, Colleen Thomas, et al.
Journal of the American Heart Association|March 9, 2022
Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE-IT PCIBenjamin E Peterson, Deepak L Bhatt, Ph Gabriel Steg, et al.
Pageof 62